This enduring activity is designed to provide healthcare professionals with a comprehensive understanding of the role of type 2 inflammation in the pathophysiology of Chronic Obstructive Pulmonary Disease (COPD) and its implications for treatment strategies. The latest developments in the treatment of COPD using approved and investigational biologics will be discussed featuring evidence-based and real-world experiences. Participants will gain valuable insights into improving the management of COPD using a multidisciplinary approach.

RELEASED DATE: May 17, 2025
EXPIRATION DATE: May 17, 2026

This enduring program consists of presentations from expert faculty and simulation challenge animations that will explain immune dysfunction and the pathogenesis of moderate-to-severe asthma, currently available and emerging targeted therapies used for asthma, and the usefulness and application of guidelines and biomarkers to guide treatment selection for this disease.

Veterans face a unique and heightened burden from moderate-to-severe asthma, experiencing worsened morbidity and mortality due to the condition. This grand rounds enduring is designed to equip healthcare professionals in the VA setting with practical, evidence-based strategies to improve care for veteran patients with moderate-to-severe asthma. Through interactive, case-based learning, participants will enhance their understanding of type 2 inflammation, gain proficiency in the use of biologic therapies, and learn to individualize treatment plans to their veteran patients’ needs, all with the goal of improving outcomes for veteran patients with moderate-to-severe asthma.

RELEASED DATE: November 21, 2025
EXPIRATION DATE: November 21, 2026

This enduring activity is designed to enhance healthcare professionals’ understanding of the role of type 2 inflammation in asthma’s complex pathology and its impact on disease progression. Participants will explore evidence-based approaches for incorporating biologic therapies into individualized treatment plans and learn strategies for selecting the most appropriate biologic therapy based on patient-specific needs, preferences, and goals to optimize outcomes in moderate-to-severe asthma management. The program will also review GINA recommendations and when to incorporate biologic therapy.

RELEASED DATE: October 30, 2025
EXPIRATION DATE: October 30, 2026

This enduring activity is designed to provide healthcare professionals with the latest evidence and strategies for managing moderate-to-severe asthma, focusing on biologic therapies. The program will review all the available tools required to make informed decisions about choosing the right biologic treatment options along with providing patient-centered communication and education to improve the overall management of patients suffering with this restrictive lung condition.

RELEASED DATE: May 17, 2025
EXPIRATION DATE: May 17, 2026

This enduring HoloModule activity is designed to provide healthcare professionals with evidence-based strategies to effectively diagnose, treat, and manage chronic obstructive pulmonary disease (COPD). It focuses on disease pathophysiology, inflammatory endotypes, and multidisciplinary, patient-centered care with the goal of improving clinical outcomes in managing COPD.

RELEASED DATE: October 30, 2025
EXPIRATION DATE: October 30, 2026

This enduring Grand Rounds program is focused on chronic obstructive pulmonary disease (COPD). It will provide you with an update on new information regarding the complex pathogenesis and pathophysiology of COPD, enhance your understanding of biologics targeting mediators of type 2 inflammation for treating COPD in appropriate patient populations, and improve your ability to provide timely referrals to COPD specialists and participate in multidisciplinary management teams (MDTs). This interactive program combines didactic instruction with case-based discussions.

RELEASED DATE: January 31, 2025
EXPIRATION DATE: January 31, 2026